quidel.com - QDEL Net Assets per Single Share

Graphic logo of Quidel Corporation (QDEL)

The market value of QuidelOrtho (QDEL), which reached 26.01 as illustrated on this chart, demonstrates a period of product portfolio transformation following the pandemic peak. The business relies on its global authority in precision rapid testing, which medical professionals trust for diagnostics. Operational efficiency is maintained by leveraging external contractors for component manufacturing and supply chain management.

Quidel Corporation (QDEL) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for quidel.com (QDEL)

- price and consensus price forecast:
Stock Price QuidelOrtho Corp|QDEL - Average Forecast Price
- market capitalization data:
Market Value QuidelOrtho Corporation|QDEL - Total Company Value
- book capitalization data:
Net Assets per Single Share QuidelOrtho|QDEL - Company Net Assets|Market Capitalization to Book Value Ratio quidel.com|QDEL - Company Assets
- debt and liquidity data:
Total Debt to Capital QuidelOrtho|QDEL - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital QuidelOrtho Corporation|QDEL - Company Aggregate Debts|Debt to Book Capitalization Ratio QuidelOrtho Corporation
Fundamental company valuation:QuidelOrtho
Manufactured product of quidel.com

The book value per share of QuidelOrtho (QDEL) reflects the portion of equity attributable to a single share. Calculating this metric by dividing net assets by the number of shares allows for an assessment of the business's intrinsic value. The current BVPS level is 26.01, demonstrating the real capitalization of resources. The BVPS trend confirms the company's resilience due to the critical importance of diagnostics. The low cyclicality of medical tests ensures capital preservation even during an economic downturn.

Competitors of QuidelOrtho (QDEL)

A (Agilent Tech) - Book Value per Share|DGX: Net Asset Value per Share|Illumina, Inc. (ILMN) - Net Assets per Single Share|EXAS (exactsciences.com) - Net Assets per Single Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Anbio Tech - Book Value per Share|Net Asset Value per Share Nordion (SHC)|OPK - Book Value per Share|Equity per Share CareDx Health CDNA|Maravai LifeSciences Holdings, Inc. - Book Value per Share|FLGT: Book Value per Share|Net Assets per Single Share Fluidigm|Cytek Corp (CTKB) - Equity per Share|OSUR (OraSure Technologies) - Book Value per Share|Book Value per Share XGN|Net Assets per Single Share MDxHealth (MDXH)|Net Assets per Single Share Lucid Diagnostics, Inc. LUCD|PRE: Accounting Value per Share|Insight Molecular Diagnostics, Inc. - Net Asset Value per Share|Net Assets per Single Share TRIB (Trinity Biotech Corp)|PRPH - Net Assets per Share|Ainos - Book Value per Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|HSCS: Net Assets per Single Share|Net Assets per Share BMRA|CDIO: Net Assets per Single Share|Book Value of One Share viraxbiolabs.com VRAX|Accounting Value per Share BJDX (Bluejay Diagnostics, Inc.)|Book Value per Share Aspira Women's Health, Inc. AWH|Book Value per Share AXDX (Accelerate Diagnostics, Inc)|CNTG - Net Assets per Share|Book Value per Share enzo.com|Fresh2 Group (FRES) - Equity per Share|Book Value per Share GENE (Genetic Technologies Ltd)|Net Asset Value per Share ME|Net Assets per Single Share Psychemedics Corp (PMD)